
AQST
Aquestive Therapeutics
$3.73
+$0.05 (+1.36%)Jul 27, 2026
Key metrics
The numbers that frame AQST today
- Market cap
- $467.93M
- P/E (TTM)
- -6.8
- EV / FCF
- -11.1
- Gross margin
- 63.5%
- EV / Sales
- 9.8
- ROIC
- -39.5%
- Div yield
- 0%
- 52wk Low
- $2.93
- 52wk High
- $7.55
Growth
Revenue and earnings trend for AQST
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AQST
Is Aquestive Therapeutics a good buy?
No. Aquestive Therapeutics has poor quality and mixed momentum. The setup is weak overall. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Aquestive Therapeutics is selling at a very high price.
What is the market capitalization of AQST?
Aquestive Therapeutics's market capitalization is $467.93M.
What is the P/E ratio for AQST stock?
Aquestive Therapeutics's current P/E ratio is -6.8.
What is the 52-week high for AQST stock?
The 52-week high for Aquestive Therapeutics is $7.55. The current close of $3.73 is 50.6% below that high.
What is the 52-week low for AQST stock?
The 52-week low for Aquestive Therapeutics is $2.93. The current close of $3.73 is 27.3% above that low.
Does AQST stock pay dividends?
Aquestive Therapeutics does not currently show a dividend per share in the company data.